Grown Rogue International (GRUSF) Non-Current Deffered Revenue (2017 - 2021)
Grown Rogue International (GRUSF) recorded quarterly Non-Current Deffered Revenue of -$8347.3 in Q4 2021, down 179.54% quarter-over-quarter from $10494.0 in Q4 2020, and down 179.54% on a YoY basis from $10494.0 in Q4 2020.
Grown Rogue International (GRUSF) Non-Current Deffered Revenue (2017 - 2021) Analysis & Trends
Grown Rogue International's Non-Current Deffered Revenue history runs 5 years deep, the most recent figure standing at -$8347.3 for Q4 2021.
- In Q4 2021, Non-Current Deffered Revenue fell 179.54% year-over-year to -$8347.3; the TTM figure through Oct 2021 stood at -$8347.3 (down 179.54% YoY), while the FY2021 annual figure was -$8345.4, down 179.53% from the prior year.
- Non-Current Deffered Revenue was -$8347.3 for Q4 2021 at Grown Rogue International, down from $10494.0 in the prior quarter.
- In the past five years, Non-Current Deffered Revenue ranged from a high of $36881.0 in Q2 2018 to a low of -$8347.3 in Q4 2021.
- Historically, Non-Current Deffered Revenue has averaged $23701.9 across 5 years, with a median of $26475.0 in 2019.
- The sharpest annual moves came in 2018 and 2021: Non-Current Deffered Revenue rose 25.47% in 2018, then sank 179.54% in 2021.
- A 5-year view of Non-Current Deffered Revenue shows it stood at $24912.0 in 2017, then gained by 25.47% to $31256.0 in 2018, then decreased by 21.6% to $24505.0 in 2019, then sank by 57.18% to $10494.0 in 2020, then tumbled by 179.54% to -$8347.3 in 2021.
- The last three Non-Current Deffered Revenue figures came in at -$8347.3 (Q4 2021), $10494.0 (Q4 2020), and $19690.0 (Q3 2020), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Grown Rogue International | - | - | 3.96 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2021 | -8,347.32 |
| Oct 31, 2020 | 10,494.00 |
| Jul 31, 2020 | 19,690.00 |
| Apr 30, 2020 | 29,400.00 |
| Jan 31, 2020 | 34,238.00 |
| Oct 31, 2019 | 24,505.00 |
| Jul 31, 2019 | 25,819.00 |
| Apr 30, 2019 | 27,131.00 |
| Jan 31, 2019 | 28,444.00 |
| Oct 31, 2018 | 31,256.00 |
| Apr 30, 2018 | 36,881.00 |
| Oct 31, 2017 | 24,912.00 |